Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYMarketing authorization granted for darolutamide in JapanPREV STORYRoche’s Risdiplam meets primary endpoint in pivotal FIREFISH trial in infants with type 1 spinal muscular atrophy